TIDMHIK
RNS Number : 6113S
Hikma Pharmaceuticals Plc
08 November 2013
Annex DTR3
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital
letters.
State whether the notification
relates to (i) a
transaction notified in
accordance with DTR 3.1.2
R,
(ii) a disclosure made in
accordance
LR 9.8.6R(1) or
(iii) a disclosure made
in accordance with section
793 of the Companies Act
Name of the issuer (2006).
1. HIKMA PHARMACEUTICALS PLC 2. (i) & (iii)
---- ---------------------------------------------- ---- --------------------------------------------------
3. Name of person discharging 4. State whether notification
managerial relates to a person
responsibilities/director connected with a person
discharging managerial responsibilities/director
SAID DARWAZAH named in 3 and identify
the connected person
N/A
---- ---------------------------------------------- ---- --------------------------------------------------
Indicate whether the notification
is in respect of a holding
of the person referred to Description of shares (including
in 3 or 4 above or in respect class), debentures or derivatives
of a nonbeneficial or financial instruments
interest 1 relating to shares
5. 3 ABOVE 6. ORDINARY SHARES OF 10P EACH
---- ---------------------------------------------- ---- --------------------------------------------------
Name of registered shareholders(s)
and, if more than one, the
number of shares held by State the nature of the
each of them transaction
CANACCORD GENUITY FOR HIKMA EXERCISE OF LTIP 2010 RELATING
7. EMPLOYEE BENEFIT TRUST 8. TO 79,800 ORDINARY SHARES
---- ---------------------------------------------- ---- --------------------------------------------------
Number of shares, debentures Percentage of issued class
or financial acquired (treasury shares
instruments relating to of that class should not
shares acquired be taken into account when
calculating percentage)
9. 79,800 10. 0.04%
---- ---------------------------------------------- ---- --------------------------------------------------
Percentage of issued class
Number of shares, debentures disposed (treasury shares
or financial of that class should not
instruments relating to be taken into account when
shares disposed calculating percentage)
11. N/A 12. N/A
---- ---------------------------------------------- ---- --------------------------------------------------
Price per share or value
of transaction Date and place of transaction
13. GBP11.95 14. 8 NOVEMBER 2013, LONDON
---- ---------------------------------------------- ---- --------------------------------------------------
15. Total holding following 16. Date issuer informed of
notification and total percentage transaction
holding following notification
(any treasury shares should
not be taken into account 8 NOVEMBER 2013
when calculating percentage)
11,126,832 (5.62%) COMPRISING:
DIRECTLY: 269,800 (0.14%)
INDIRECTLY THROUGH DARHOLD
LIMITED: 10,857,032 (5.49%)
---- ---------------------------------------------- ---- --------------------------------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer
complete the following boxes
Date of grant Period during which
or date on which exercisable
17. N/A 18. N/A
---- --------------------------- ---- ------------------------------
Total amount paid Description of shares
(if any) for grant or debentures involved
of the option (class and number)
19. N/A 20. N/A
---- --------------------------- ---- ------------------------------
Exercise price (if
fixed at time of grant) Total number of shares
or or debentures over
indication that price which options held
is to be fixed at following notification
the time of exercise
21. N/A 22. N/A
---- --------------------------- ---- ------------------------------
Name of contact and
telephone number for
Any additional information queries
PETER SPEIRS 0207
23. N/A 24. 399 2772
---- --------------------------- ---- ------------------------------
Name of authorised official of issuer responsible
for making notification
Peter Speirs, Company Secretary
Date of notification 8 November 2013
--------------------------------------------------
Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.
(1) An issuer making a notification in respect
of a transaction relating to the shares
or debentures of the issuer should complete
boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect
of a derivative relating the shares of
the issuer should complete boxes 1 to
4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect
of options granted to a director/person
discharging managerial responsibilities
should complete boxes 1 to 3 and 17 to
24.
(4) An issuer making a notification in respect
of a financial instrument relating to
the shares of the issuer (other than a
debenture) should complete boxes 1 to
4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Annex DTR3
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital
letters.
State whether the notification
relates to (i) a
transaction notified in
accordance with DTR 3.1.2
R,
(ii) a disclosure made in
accordance
LR 9.8.6R(1) or
(iii) a disclosure made
in accordance with section
793 of the Companies Act
Name of the issuer (2006).
1. HIKMA PHARMACEUTICALS PLC 2. (i) & (iii)
---- ---------------------------------------------- ---- --------------------------------------------------
3. Name of person discharging 4. State whether notification
managerial relates to a person
responsibilities/director connected with a person
discharging managerial responsibilities/director
MAZEN DARWAZAH named in 3 and identify
the connected person
N/A
---- ---------------------------------------------- ---- --------------------------------------------------
Indicate whether the notification
is in respect of a holding
of the person referred to Description of shares (including
in 3 or 4 above or in respect class), debentures or derivatives
of a nonbeneficial or financial instruments
interest 1 relating to shares
5. 3 ABOVE 6. ORDINARY SHARES OF 10P EACH
---- ---------------------------------------------- ---- --------------------------------------------------
Name of registered shareholders(s)
and, if more than one, the
number of shares held by State the nature of the
each of them transaction
CANACCORD GENUITY FOR HIKMA EXERCISE OF LTIP 2010 RELATING
7. EMPLOYEE BENEFIT TRUST 8. TO 53,200 ORDINARY SHARES
---- ---------------------------------------------- ---- --------------------------------------------------
Number of shares, debentures Percentage of issued class
or financial acquired (treasury shares
instruments relating to of that class should not
shares acquired be taken into account when
calculating percentage)
9. 53,200 10. 0.03%
---- ---------------------------------------------- ---- --------------------------------------------------
Percentage of issued class
Number of shares, debentures disposed (treasury shares
or financial of that class should not
instruments relating to be taken into account when
shares disposed calculating percentage)
11. N/A 12. N/A
---- ---------------------------------------------- ---- --------------------------------------------------
Price per share or value
of transaction Date and place of transaction
13. GBP11.95 14. 8 NOVEMBER 2013, LONDON
---- ---------------------------------------------- ---- --------------------------------------------------
15. Total holding following 16. Date issuer informed of
notification and total percentage transaction
holding following notification
(any treasury shares should
not be taken into account 8 NOVEMBER 2013
when calculating percentage)
6,920,685 (3.50%) COMPRISING:
DIRECTLY: 791,425 (0.40%)
INDIRECTLY THROUGH DARHOLD
LIMITED: 6,129,260 (3.10%)
---- ---------------------------------------------- ---- --------------------------------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer
complete the following boxes
Date of grant Period during which
or date on which exercisable
17. N/A 18. N/A
---- --------------------------- ---- ------------------------------
Total amount paid Description of shares
(if any) for grant or debentures involved
of the option (class and number)
19. N/A 20. N/A
---- --------------------------- ---- ------------------------------
Exercise price (if
fixed at time of grant) Total number of shares
or or debentures over
indication that price which options held
is to be fixed at following notification
the time of exercise
21. N/A 22. N/A
---- --------------------------- ---- ------------------------------
Name of contact and
telephone number for
Any additional information queries
PETER SPEIRS 0207
23. N/A 24. 399 2772
---- --------------------------- ---- ------------------------------
Name of authorised official of issuer responsible
for making notification
Peter Speirs, Company Secretary
Date of notification 8 November 2013
--------------------------------------------------
Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.
(1) An issuer making a notification in respect
of a transaction relating to the shares
or debentures of the issuer should complete
boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect
of a derivative relating the shares of
the issuer should complete boxes 1 to
4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect
of options granted to a director/person
discharging managerial responsibilities
should complete boxes 1 to 3 and 17 to
24.
(4) An issuer making a notification in respect
of a financial instrument relating to
the shares of the issuer (other than a
debenture) should complete boxes 1 to
4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Annex DTR3
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital
letters.
State whether the notification
relates to (i) a
transaction notified in
accordance with DTR 3.1.2
R,
(ii) a disclosure made in
accordance
LR 9.8.6R(1) or
(iii) a disclosure made
in accordance with section
793 of the Companies Act
Name of the issuer (2006).
1. HIKMA PHARMACEUTICALS PLC 2. (i) & (iii)
---- ---------------------------------------------- ---- --------------------------------------------------
3. Name of person discharging 4. State whether notification
managerial relates to a person
responsibilities/director connected with a person
discharging managerial responsibilities/director
KHALID NABILSI named in 3 and identify
the connected person
N/A
---- ---------------------------------------------- ---- --------------------------------------------------
Indicate whether the notification
is in respect of a holding
of the person referred to Description of shares (including
in 3 or 4 above or in respect class), debentures or derivatives
of a nonbeneficial or financial instruments
interest 1 relating to shares
5. 3 ABOVE 6. ORDINARY SHARES OF 10P EACH
---- ---------------------------------------------- ---- --------------------------------------------------
Name of registered shareholders(s)
and, if more than one, the
number of shares held by State the nature of the
each of them transaction
CANACCORD GENUITY NOMINEE DISPOSAL OF 49,000 ORDINARY
7. ACCOUNT 8. SHARES
---- ---------------------------------------------- ---- --------------------------------------------------
Percentage of issued class
Number of shares, debentures acquired (treasury shares
or financial of that class should not
instruments relating to be taken into account when
shares acquired calculating percentage)
9. N/A 10. N/A
---- ---------------------------------------------- ---- --------------------------------------------------
Percentage of issued class
Number of shares, debentures disposed (treasury shares
or financial of that class should not
instruments relating to be taken into account when
shares disposed calculating percentage)
11. 49,000 12. 0.025%
---- ---------------------------------------------- ---- --------------------------------------------------
Price per share or value
of transaction Date and place of transaction
13. GBP11.95 14. 8 NOVEMBER 2013, LONDON
---- ---------------------------------------------- ---- --------------------------------------------------
15. Total holding following 16. Date issuer informed of
notification and total percentage transaction
holding following notification
(any treasury shares should
not be taken into account 8 NOVEMBER 2013
when calculating percentage)
170,847 (0.09%)
---- ---------------------------------------------- ---- --------------------------------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer
complete the following boxes
Date of grant Period during which
or date on which exercisable
17. N/A 18. N/A
---- --------------------------- ---- ------------------------------
Total amount paid Description of shares
(if any) for grant or debentures involved
of the option (class and number)
19. N/A 20. N/A
---- --------------------------- ---- ------------------------------
Exercise price (if
fixed at time of grant) Total number of shares
or or debentures over
indication that price which options held
is to be fixed at following notification
the time of exercise
21. N/A 22. N/A
---- --------------------------- ---- ------------------------------
Name of contact and
telephone number for
Any additional information queries
PETER SPEIRS 0207
23. N/A 24. 399 2772
---- --------------------------- ---- ------------------------------
Name of authorised official of issuer responsible
for making notification
Peter Speirs, Company Secretary
Date of notification 8 November 2013
--------------------------------------------------
Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.
(1) An issuer making a notification in respect
of a transaction relating to the shares
or debentures of the issuer should complete
boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect
of a derivative relating the shares of
the issuer should complete boxes 1 to
4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect
of options granted to a director/person
discharging managerial responsibilities
should complete boxes 1 to 3 and 17 to
24.
(4) An issuer making a notification in respect
of a financial instrument relating to
the shares of the issuer (other than a
debenture) should complete boxes 1 to
4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBUBDBDGGBGXI
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
